Sandra R. Karrmann
Known title: Chief Human Resources OfficerCIK: 0001354100
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Kimberly-Clark Guidance Reiterated as Sales Slip, Bond Sale Planned. Kimberly‑Clark confirmed its full‑year guidance even though recent sales were weaker than expected, which analysts at UBS said could help keep the stock stable. The company is also preparing a bond issuance to fund its planned purchase of a Tylenol‑making business. Shares have fallen about 13% and are trading near a long‑standing support level, while the dividend growth streak faces pressure. The mixed performance of consumer stocks and the stock’s inclusion in dividend‑focused lists add further context.
Transaction History
| JYNT | ▲ Buy | Grant | 5,714 | $0 | 5/20/2026 | View on chart |
| JYNT | ▲ Buy | Grant | 4,849 | $0 | 6/3/2025 | View on chart |
| KMB | ▲ Buy | Option Exercise | 1,138 | $0 | 5/1/2025 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 448 | $58K | 5/1/2025 | View on chart |
| KMB | ▲ Buy | Option Exercise | 1,123 | $0 | 4/26/2025 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 443 | $58K | 4/26/2025 | View on chart |
| KMB | ▲ Buy | Grant | 14,138 | $0 | 2/28/2025 | View on chart |
| KMB | ▲ Buy | Option Exercise | 4,284 | $0 | 2/28/2025 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 1,686 | $239K | 2/28/2025 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 5,564 | $790K | 2/28/2025 | View on chart |
| KMB | ▲ Buy | Option Exercise | 1,084 | $0 | 4/26/2024 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 427 | $58K | 4/26/2024 | View on chart |
| KMB | ▼ Sell | Open Market | 6,288 | $863K | 4/24/2024 | View on chart |
| KMB | ▲ Buy | Grant | 11,305 | $0 | 2/26/2024 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 4,449 | $539K | 2/26/2024 | View on chart |
| KMB | ▲ Buy | Option Exercise | 9,067 | $0 | 10/30/2023 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 3,569 | $427K | 10/30/2023 | View on chart |
| KMB | ▼ Sell | Open Market | 5,122 | $665K | 8/29/2023 | View on chart |
| KMB | ▲ Buy | Option Exercise | 8,752 | $0 | 10/30/2022 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 2,524 | $314K | 10/30/2022 | View on chart |
| KMB | ▲ Buy | Option Exercise | 8,446 | $0 | 10/30/2021 | View on chart |
| KMB | ▼ Sell | Tax Withholding | 3,324 | $430K | 10/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Always Best Care Appoints New CFO
Always Best Care, a subsidiary of The Joint Corp., has named Jason Shontz as its new Chief Financial Officer. This leadership change is relevant as it signals a shift in financial oversight for the company. The stock is currently trading near its 52-week low, with technical indicators showing weakness.
Always Best Care Appoints New CFO. Always Best Care, a subsidiary of The Joint Corp., has named Jason Shontz as its new Chief Financial Officer. This leadership change is relevant as it signals a shift in financial oversight for the company. The stock is currently trading near its 52-week low, with technical indicators showing weakness.